Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3 med./bio.

By: Kim JY, Jo Y, Oh HK, Kim EH
Published in: Am J Cancer Res 2020; 10 (10): 3475-3486
Download citation in RIS format

Exposure